Genzyme recalls some kidney transplant drugs Boston Herald Genzyme Corp. has recalled nine lots of thymoglobulin, a medication designed to treat acute kidney transplant rejection, according to the U.S. Food and Drug Administration. The recall was initiated when one thymoglobulin lot failed a periodic stability ... Genzyme recalls transplant drug |
